Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | MGLL | Q99685 | 6/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL1344847 | 0.87 | ALDH1A1 (0.52) | TDP1MGLLALDH1A1 | |
| Phenol SCHEMBL28110498 | 0.87 | TDP1 (0.44) | TDP1MGLLALDH1A1 | |
| Phenol SCHEMBL11893427 | 0.87 | TDP1 (0.44) | TDP1MGLLALDH1A1 | |
| Phthalic Acid SCHEMBL27764559 | 0.85 | TDP1 (0.42) | TDP1MGLLALDH1A1 | |
| Phthalic Acid SCHEMBL28602778 | 0.85 | TDP1 (0.42) | TDP1MGLLALDH1A1 | |
| Acrylic Acid SCHEMBL23458826 | 0.84 | ALDH1A1 (0.55) | TDP1MGLLALDH1A1 | |
| Acrylic Acid SCHEMBL237309 | 0.84 | ALDH1A1 (0.55) | TDP1MGLLALDH1A1 | |
| SCHEMBL4401481 | 0.84 | TDP1 (0.52) | TDP1MGLLALDH1A1GLA | |
| Hydroquinone SCHEMBL28109700 | 0.83 | ALDH1A1 (0.44) | TDP1MGLLALDH1A1 | |
| SCHEMBL1240963 | 0.82 | MGLL (0.51) | MGLLALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090306422-A1 | OLIGOMERIC URETHANE ACRYLATES, THEIR PREPARATION AND USE | BASF COATINGS AG (DE) | 2009-12-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090306422-A1 | OLIGOMERIC URETHANE ACRYLATES, THEIR PREPARATION AND USE | NOX1, CBR1, NOXO1 | TDP1 1277/4885MGLL 3281/4885ALDH1A1 589/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.